Functionally, STAT3 overexpression not only promoted ESCC cell proliferation and migration but also significantly attenuated the suppressive effects of fedratinib on these processes (Figures 3C,D; Supplementary Figure S5A,B). This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.